We pursue three complimentary research platforms

1.   Clinical trials

Clinical trials of targeted therapies in breast cancer, including early Phase (0, I and II) studies, encompassing breast cancer prevention, neo-adjuvant therapy, and treatment of advanced disease.

​

These studies will enable innovative Phase III trials that require companion biomarker evaluation.

​

2.   Breast Biomarker Program

The Breast Biomarker Program coordinates the prospective collection and testing of tumour samples.

 

These samples are evaluated for molecular markers to guide patient selection for suitable clinical trials and therapy.

​

3.   DCISion

Building a bank of highly annotated DCIS (Pre-invasive Breast Cancer) tissue samples for biomarker research.

​